Carl Gerrard, Shire’s senior manager business analysis and forecasting, explains how forecasters can leverage company resources to optimize forecasts
Michael Turner, vice president, brand management practice, Campbell Alliance, on creating structured forecasts that account for unpredictability
How adaptive design can reduce development times for drug and provide earlier long-term safety data
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast
Nader Rizkalla explains why, given the political turmoil in the region, forecasting the Middle Eastern market requires local business experience
In the run up to Forecasting Europe on June 14-15 in Berlin, Prasad V. Saraph, supply chain excellence manager at Bayer, explains why effective forecasting is imperative for survival
*In the run up to Forecasting Europe [1] in Berlin in June, eyeforpharma asked some of our key speakers for their ins* [1] http://www.eyeforpharma.com/forecastingeu/
*Peter Mansell examines the business arguments for centralized versus departmental or regional forecasting*
Dennis Van Liew, senior director and site head for strategic management at Sandwich Laboratories, Pfizer EU, on why commercial and research teams should work together to forecast the commercial potential of pipeline products.
Wa el Hashad, vice president at Boehringer Ingelheim, urges forecasting flexibility throughout the life of the product.
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Andrew Tolve explores how digital health coaching is helping the healthcare industry provide cost-effective services that boost adherence
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs